Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Interest

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

363.71

582.65

-218.94

-37.58%

Other Operating Income

0.00

Total Operating income

363.71

582.65

-218.94

-37.58%

Raw Material Cost

80.31

309.11

-228.80

-74.02%

Purchase of Finished goods

24.56

50.95

-26.39

-51.80%

(Increase) / Decrease In Stocks

-8.65

-55.79

47.14

84.50%

Employee Cost

60.39

102.40

-42.01

-41.03%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

107.50

114.86

-7.36

-6.41%

Total Expenditure (Excl Depreciation)

264.11

521.53

-257.42

-49.36%

Operating Profit (PBDIT) excl Other Income

99.60

61.12

38.48

62.96%

Other Income

3.88

1.48

2.40

162.16%

Operating Profit (PBDIT)

103.48

62.60

40.88

65.30%

Interest

0.14

28.51

-28.37

-99.51%

Exceptional Items

31.80

76.40

-44.60

-58.38%

Gross Profit (PBDT)

135.14

110.49

24.65

22.31%

Depreciation

6.02

25.73

-19.71

-76.60%

Profit Before Tax

129.12

84.76

44.36

52.34%

Tax

32.97

11.83

21.14

178.70%

Provisions and contingencies

0.00

Profit After Tax

96.15

72.93

23.22

31.84%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

96.15

72.93

23.22

31.84%

Equity Capital

16.60

92.17

-75.57

-81.99%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

57.92

7.91

50.01

632.24%

Diluted Earnings per share

57.92

7.91

50.01

632.24%

Operating Profit Margin (Excl OI)

27.38%

10.49%

0.00

16.89%

Gross Profit Margin

37.16%

18.96%

0.00

18.20%

PAT Margin

26.44%

12.52%

0.00

13.92%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 363.71 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -1.82% vs -0.91% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.37% vs 19.33% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 96.15 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 1.64% vs 21.92% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 45.29% vs 294.40% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 99.60 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -26.54% vs 22.75% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 10.25% vs 87.23% in Jun 2025

Quarterly - Interest

Interest 0.14 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -33.33% vs 110.00% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 16.67% vs -40.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 27.38%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025